JP Morgan Chase’s Enzymotec Ltd ENZY Stock Holding History

JP Morgan Chase’s Portfolio ENZY Stock Details ENZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,658	Closed	-$79K	–	5817
2017 Q4	$79K	Sell	6,658 -2,643	-28%	-$30.7K	﹤0.01%	4748
2017 Q3	$107K	Buy	+9,301	New	+$91.8K	﹤0.01%	4285
2017 Q1	–	Sell	-5,760	Closed	-$38K	–	5364
2016 Q4	$38K	Buy	5,760 +500	+10%	+$3.29K	﹤0.01%	4602
2016 Q3	$37K	Buy	5,260 +1,700	+48%	+$13.6K	﹤0.01%	4090
2016 Q2	$30K	Buy	+3,560	New	+$29.5K	﹤0.01%	4155

JP Morgan Chase's ENZY Position: Q1 2018 in Review

JP Morgan Chase sold out of Enzymotec Ltd (ENZY) in Q1 2018, closing a stake of 6,658 shares — an estimated $79K sold.

JP Morgan Chase first reported a position in ENZY in Q2 2016 and held it in 5 quarters. The position peaked at $107K in Q3 2017. 0 funds tracked by Wall St. Rank hold ENZY as of Q1 2018.

JP Morgan Chase reported no remaining Enzymotec Ltd position as of Q1 2018 after selling out during the quarter.
JP Morgan Chase sold 6,658 Enzymotec Ltd shares in Q1 2018, an estimated $79K.
JP Morgan Chase first reported a position in Enzymotec Ltd in Q2 2016 and held it in 5 quarters.
JP Morgan Chase's Enzymotec Ltd position peaked at $107K in Q3 2017.
0 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2018.

Based on JP Morgan Chase's 13F filing for Q1 2018, filed 10 May 2018.